Hikma Pharmaceuticals PLC (HKMPY)
OTCMKTS · Delayed Price · Currency is USD
50.74
-2.52 (-4.73%)
Aug 1, 2025, 3:59 PM EDT
DISH Network Market Cap
Hikma Pharmaceuticals has a market cap or net worth of $5.65 billion as of August 5, 2025. Its market cap has increased by 4.87% in one year.
Market Cap
5.65B
Enterprise Value
6.82B
Revenue
3.13B
Ranking
n/a
PE Ratio
15.74
Stock Price
$50.74
Market Cap Chart
Since November 2, 2005, Hikma Pharmaceuticals's market cap has increased from 833.84M to 5.65B, an increase of 577.54%. That is a compound annual growth rate of 10.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 5.66B | 2.33% |
| Dec 31, 2024 | 5.53B | 9.82% |
| Dec 29, 2023 | 5.04B | 22.33% |
| Dec 30, 2022 | 4.12B | -40.78% |
| Dec 31, 2021 | 6.95B | -12.23% |
| Dec 31, 2020 | 7.92B | 24.01% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 823.67M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 519.96M |
| Glass House Brands | 438.99M |
| American Oncology Network | 408.39M |
| Northwest Biotherapeutics | 376.73M |
| CytoDyn | 366.82M |